BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03194893-completion@plaintrial.com
DTSTAMP:20261027T083437Z
DTSTART;VALUE=DATE:20260530
SUMMARY:A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma 
 Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Can
 cer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03194893
URL:https://plaintrial.com/trial/NCT03194893
END:VEVENT
END:VCALENDAR